Stockreport

Recursion Announces Plans to Open New Office in London

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today a [Read more]